Trial intelligence / Profile preview

Fentanyl plus ketamine for pain relief in methadone users with limb fracture

IRCT20171030037093N25Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Sep 2019
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of fentanyl and ketamine in limb fracture and acute pain, sponsored by Isfahan University of Medical Sciences. Primary endpoint: Pain relief. Started Sep 2019; status: completed.

02

Drugs

fentanylketamine
03

Conditions

limb fractureacute pain

Beyond the preview

Go deeper on IRCT20171030037093N25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171030037093N25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call